Loading…
Global Longlife Hospital and Research (BSE 543520)₹14.53+0.55%Hospital
Global Longlife Hospital and Research is compared with the 10 closest in size in Hospital (41 companies in the industry). It has a ROCE of −3.9% against a peer median of 3.6%. By market cap it is #10 of 11 in this set.
As of · Peer set: 10 closest in size in Hospital
| Company | M-cap (₹ Cr) | P/E | ROCE % | ROE % | Debt / equity | Div. yield % | Sales (₹ Cr) | Net profit (₹ Cr) | Qtr sales growth % | Qtr profit growth % | Compare |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Abate As Industries | 121 | 9.4 | 7.0 | 5.1 | 0.06 | 0.0 | 159 | 12 | −44.4 | −0.4 | vs BSE 543520 |
| Fortis Malar Hospitals | 84 | 898.0 | 14.7 | 12.8 | 0.00 | 0.0 | 0 | 4 | −100.0 | −96.6 | vs BSE 543520 |
| Sangani Hospitals | 80 | 26.6 | 17.0 | 7.8 | 0.04 | 0.0 | 107 | 4 | 682.1 | 198.0 | vs BSE 543520 |
| Maitreya Medicare | 80 | — | −1.9 | −9.4 | 0.80 | 0.0 | 42 | −2 | −0.0 | — | vs BSE 543520 |
| Shanmuga Hospital | 61 | 14.6 | 12.7 | 10.2 | 0.16 | 0.0 | 47 | 4 | −1.9 | 21.7 | vs BSE 543520 |
| Aatmaj Healthcare | 57 | 78.1 | 3.6 | 1.4 | 0.41 | 0.0 | 24 | 1 | 22.5 | −38.2 | vs BSE 543520 |
| ABH Healthcare | 46 | 5.7 | 19.9 | 39.6 | 3.18 | 0.0 | 52 | 6 | — | — | vs BSE 543520 |
| KK Shah Hospitals | 31 | — | −5.5 | −4.7 | 0.00 | 0.0 | 9 | −1 | −7.5 | — | vs BSE 543520 |
| Soni Medicare | 30 | — | −12.1 | −9,033.0 | 8.15 | 0.0 | 26 | −3 | −12.5 | −205.6 | vs BSE 543520 |
| Global Longlife Hospital and Research | 15 | — | −3.9 | −6.8 | 0.00 | 0.0 | 0 | −2 | — | — | — |
| Broach Lifecare Hospital | 8 | 90.7 | 2.5 | 1.0 | 0.00 | 0.0 | 6 | 0 | 146.4 | −340.0 | vs BSE 543520 |
| Peer median | 57 | 26.6 | 3.6 | 1.4 | 0.06 | 0.0 | 26 | 1 | −1.9 | −38.2 |
Listed companies closest to Global Longlife Hospital and Research in Hospital include Abate As Industries, Fortis Malar Hospitals, Sangani Hospitals, Maitreya Medicare, Shanmuga Hospital, Aatmaj Healthcare, ABH Healthcare, KK Shah Hospitals.
Abate As Industries, with a market cap of ₹121 Cr.
Global Longlife Hospital and Research's return on capital employed is −3.9%, below the peer median of 3.6%.